Molson Coors Beverage Company 2023 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2023. This is an annual Form 10-K; the filing does not present a standalone fourth-quarter income statement. Results are reported in U.S. dollars under U.S. GAAP and cover the Americas and EMEA&APAC segments.
Business Context
Molson Coors produces, markets and distributes beer and adjacent beverages, including flavored malt beverages, spirits, ready-to-drink products and non-alcoholic beverages. Core brands include Coors Light, Miller Lite, Coors Banquet, Molson Canadian, Carling and Ožujsko. The October 2023 Acceleration Plan prioritizes core power-brand growth, premiumization, expansion beyond beer, capability investments and support for employees, communities and the planet.
Key Financial Metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Net sales | $11,702.1 million | $10,701.0 million | +9.4% |
| Gross profit | $4,368.8 million | $3,655.2 million | +19.5% |
| Operating income | $1,438.2 million | $157.5 million | Increase primarily from cycling 2022 goodwill impairment |
| Net income attributable to MCBC | $948.9 million | $(175.3) million | Returned to profitability |
| Diluted EPS | $4.37 | $(0.81) | Improved materially |
| Financial volume | 83.772 million hectoliters | 82.272 million hectoliters | +1.8% |
| Cash flow from operations | $2,079.0 million | $1,502.0 million | +$577.0 million |
| Capital expenditures paid | $671.5 million | $661.4 million | +$10.1 million |
| Cash and cash equivalents | $868.9 million | $600.0 million | +$268.9 million |
Gross margin was approximately 37.3% in 2023 versus 34.2% in 2022. Operating margin was approximately 12.3% versus 1.5%, while the 2022 comparison was heavily affected by an $845.0 million non-cash goodwill impairment charge. The 2023 effective tax rate was 23.6%.
Segment Performance and Material Changes
- Americas: Net sales increased 8.2% to $9,425.2 million, with financial volume up 3.6%. Growth reflected core-brand volume gains, pricing, favorable mix and recovery from the 2022 Quebec labor strike. Income before taxes increased to $1,566.7 million from $312.9 million, primarily because the 2022 period included the $845.0 million goodwill impairment.
- EMEA&APAC: Net sales increased 14.5% to $2,296.1 million despite a 3.0% volume decline. Pricing, premiumization and currency benefits were offset by consumer weakness and inflation in Central and Eastern Europe. The segment reported a $41.1 million pretax loss versus $61.0 million of pretax income in 2022.
- Cost pressures: Materials and manufacturing inflation remained significant, although management reported moderation in the second half of 2023. Cost savings, pricing, volume leverage and a $126.9 million favorable change in unrealized commodity derivative mark-to-market positions helped offset inflation.
- Unusual items: The company recorded a $160.7 million partial impairment of the Staropramen brand intangible asset and an $11.1 million loss on the sale of its controlling interest in Truss. It also acquired a 75% interest in Blue Run, a high-end whiskey business, for approximately $77 million.
Debt, Liquidity and Capital Allocation
- Total debt obligations were approximately $6.18 billion at December 31, 2023, including $904.6 million due in 2024 and $2.38 billion due in 2026. Long-term debt on the balance sheet was $5.31 billion, compared with $6.17 billion at year-end 2022.
- The company repaid CAD 500 million of 2.84% notes at maturity in July 2023 using cash on hand.
- A $2.0 billion revolving credit facility was extended to June 2028. It was undrawn at year-end, and the company had no commercial paper borrowings. The company reported compliance with debt covenants, including a maximum defined net debt-to-EBITDA ratio of 4.00x.
- Cash flow from operations was $2.08 billion, compared with $1.50 billion in 2022. Financing cash outflows included $354.7 million of dividends and $205.8 million of treasury-stock purchases.
- The company declared dividends of $1.64 per share during 2023 and approved a $2.0 billion, five-year Class B share-repurchase authorization. It repurchased 3.45 million shares for approximately $211.0 million during the year, with approximately $1.8 billion remaining under the authorization.
- Credit ratings were BBB/Stable from Standard & Poor’s, Baa2/Positive from Moody’s and BBB/Stable from DBRS.
Outlook, Commentary and Risks
Management expects inflationary pressures to moderate in 2024 and intends to use pricing, hedging, premiumization and cost savings to protect margins. The filing does not provide a clear consolidated 2024 sales, earnings or cash-flow guidance figure.
- The Americas goodwill reporting unit had approximately $5.3 billion of goodwill remaining and was less than 15% above carrying value in the October 2023 test, creating heightened future impairment risk.
- The Staropramen brand had a $426.9 million carrying value after the 2023 impairment and was also identified as being at heightened risk of further impairment.
- Ontario will not renew the existing beer distribution and retail framework after December 31, 2025. Planned changes beginning in 2026 may expand beer sales to grocery, convenience, gas-station and big-box retailers; the ultimate financial impact remains under evaluation.
- A strike at the Fort Worth, Texas brewery began February 17, 2024. Management stated that contingency plans were in place, but the filing does not quantify the potential impact.
- Principal risks include commodity and supply-chain inflation, weaker discretionary consumer spending, competition and changing beverage preferences, foreign-exchange volatility, labor disruptions, cybersecurity, water availability, climate and environmental regulation, legal contingencies, distributor dependence and debt-refinancing risk.
- The company had $70.2 million of accrued litigation, dispute and environmental liabilities at year-end. The Keystone litigation accrual was $58.5 million, and the company’s appeal remained pending.
- Ontario distribution changes, the Russia-Ukraine conflict, evolving alcohol regulation, tax-law changes and the ability to execute the Acceleration Plan could materially affect future results.
Investor Verification Checklist
- Verify 2024 performance against management’s stated assumptions for inflation moderation, pricing, premiumization, core-brand volume and beyond-beer growth.
- Monitor Americas goodwill and Staropramen impairment sensitivity to volume, cash-flow forecasts, discount rates and consumer demand.
- Assess the cash-flow impact of the $904.6 million of 2024 debt maturities and the EUR 800 million notes due July 2024.
- Follow the Fort Worth labor dispute and any resulting production, shipment or margin effects.
- Evaluate the final Ontario retail and distribution framework and its implications for pricing, channel mix, margins and market access.
- Review the Keystone appeal, environmental matters and Kaiser indemnities for changes in expected cash outflows.
- Reconcile reported sales growth with the contribution from pricing, mix, volume and foreign currency, particularly given the 3.0% volume decline in EMEA&APAC.